Journal
STEM CELL RESEARCH
Volume 59, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.scr.2021.102648
Keywords
-
Funding
- Institute of Cytology and Genetics, Novosibirsk, Russia [121031800061-7, 0259-2021-0016]
Ask authors/readers for more resources
By using induced pluripotent stem cell (iPSC) lines, iCS-MAF1-1 and iCS-MAF1-11, researchers aim to describe the early stages of neurogenesis and identify key developmental stages where phenotypic manifestations of mutations in the VPS13B gene are found.
The human induced pluripotent stem cell (iPSC) lines, iCS-MAF1-1 and iCS-MAF1-11, were generated from fibroblasts. The donor has a heterozygous mutation in the VPS13B gene, which manifests in her child as Cohen syndrome. It is a Golgi pathology, characterized by postnatal microcephaly and delayed growth and mental development. However, the process underlying pathological changes leading to the onset of the disease is still unknown. The use of iPSC will allow describing the early stages of neurogenesis, which is undoubtedly relevant for identifying key stages of development, at which phenotypic manifestations of mutations in the VPS13B gene are found.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available